HTG Molecular Diagnostics, Inc.'s mission is to empower precision medicine at the local level. The company’s proprietary HTG EdgeSeq technology automates multiplexed molecular profiling of nucleic acids in a wide variety of solid and liquid samples, even when very limited in amount. The extraction free workflow paired with detection by next-generation sequencing offers many advantages and enables meaningful applications, such as identifying biomarkers important for precision medicine, understanding the clinical relevance of these biomarkers, and, ultimately, identifying treatment options.
|Summary Toggle Jun 1, 2015 from 1:30 PM to 1:30 PM PDT|
|Summary Toggle Jun 23, 2015 from 2:00 PM to 2:00 PM EDT||
|Summary Toggle Aug 6, 2015 from 1:30 PM to 1:30 PM PDT|
|Summary Toggle Aug 13, 2015 from 9:00 AM to 9:00 AM EDT||
|Summary Toggle Nov 12, 2015 from 1:30 PM to 1:30 PM PST|
Copyright West LLC. Minimum 15 minutes delayed.